A patient with an acute inferior myocardial infarction complicated by right-sided heart involvement and pulmonary edema has recently undergone successful resuscitation from ventricular fibrillation. The patient remains hemodynamically unstable, with hypotension and renal impairment. Which nursing intervention should take priority to optimize the patient's hemodynamic status and prevent further complications?

B) Administer an inotropic agent as prescribed to support cardiac output.

A) Increase the infusion rate of intravenous fluids to improve renal perfusion.

B) Administer an inotropic agent as prescribed to support cardiac output.

C) Initiate a continuous renal replacement therapy to manage fluid overload.

D) Provide high-flow oxygen therapy to correct oxygen desaturation.

A nurse is caring for a patient with an acute inferior myocardial infarction complicated by ventricular fibrillation, reduced renal function, and pulmonary edema. Which of the following interventions should be prioritized to stabilize the patient's condition?

C) Prepare for immediate percutaneous coronary intervention (PCI) to restore coronary perfusion.

A) Administer intravenous fluids to increase blood pressure and perfusion.

B) Initiate high-dose loop diuretics to manage pulmonary edema.

C) Prepare for immediate percutaneous coronary intervention (PCI) to restore coronary perfusion.

D) Administer sodium bicarbonate to address potential metabolic acidosis.

A patient with an inferior myocardial infarction has developed moderate mitral regurgitation and persistent ST-segment elevation. The multidisciplinary team has initiated medical management with increased intravenous nitroglycerin and a low-dose infusion of furosemide. The nurse is reviewing the patient's response to treatment. Which assessment finding would indicate the need to escalate care and potentially consider invasive interventions such as an intra-aortic balloon pump (IABP)?

A) Decreased urine output despite increased diuretic therapy

B) Improvement in respiratory distress and decreased pulmonary congestion

C) Stabilization of blood pressure with nitroglycerin therapy

D) Resolution of ST-segment elevation on the ECG

A patient with acute decompensated heart failure presents with increased respiratory distress, decreased oxygen saturation to 85% on high-flow nasal cannula, and new-onset atrial fibrillation. Despite diuretic therapy, urine output remains low, and creatinine levels are rising. Arterial blood gas analysis shows mixed respiratory and metabolic acidosis. What is the most appropriate initial nursing intervention to address the patient's respiratory compromise?

A) Increase the flow rate of the high-flow nasal cannula

C) Administer intravenous beta-blockers to control heart rate

D) Prepare for emergent intubation and mechanical ventilation

A patient with heart failure is exhibiting acute decompensation with respiratory distress, decreased urine output, and metabolic acidosis. Despite the administration of furosemide, the patient's condition continues to worsen. As the nurse, what is the most appropriate next step in the management of this patient?

D) Prepare for the initiation of non-invasive positive pressure ventilation.

A) Increase the dose of furosemide to enhance diuresis.

B) Initiate continuous renal replacement therapy (CRRT) immediately.

C) Administer a bolus of normal saline to improve renal perfusion.

D) Prepare for the initiation of non-invasive positive pressure ventilation.

A patient with acute kidney injury and hemodynamic instability secondary to cardiac failure has recently developed a suspected systemic infection. Which nursing intervention is priority when managing this patient's complex condition?

D) Administer broad-spectrum antibiotics immediately after obtaining blood cultures.

A) Increase the frequency of monitoring vital signs to every hour to detect changes promptly.

B) Adjust the dosage of vasopressors to maintain a stable blood pressure above 90/60 mmHg.

C) Initiate strict intake and output monitoring to manage fluid balance accurately.

D) Administer broad-spectrum antibiotics immediately after obtaining blood cultures.

A patient in the ICU with a history of heart failure and recent placement of an intra-aortic balloon pump develops a sudden spike in body temperature to 39°C, leukocytosis with a WBC count of 16,000/mm³, and is started on broad-spectrum antibiotics. In light of the new development of possible systemic infection, which of the following nursing interventions is the highest priority?

A) Increase the frequency of vital signs monitoring to every 30 minutes.

B) Prepare the patient for immediate surgical intervention for mitral valve repair.

C) Initiate contact precautions until the source of infection is identified.

D) Collaborate with the nephrology team to start continuous renal replacement therapy as soon as possible.

A patient in the critical care unit has developed significant mitral regurgitation and a small vegetation on the mitral valve following a myocardial infarction. The patient also presents with persistent hyperkalemia despite CRRT. Which nursing intervention should be prioritized to stabilize the patient's condition and prevent further complications?

C) Monitor cardiac rhythm closely and administer calcium gluconate and insulin with glucose to manage hyperkalemia.

A) Administer sodium bicarbonate to correct metabolic acidosis and enhance renal potassium excretion.

B) Prepare the patient for emergent mitral valve surgery to address the regurgitation and vegetation.

C) Monitor cardiac rhythm closely and administer calcium gluconate and insulin with glucose to manage hyperkalemia.

D) Increase the dose of vasopressors to improve myocardial perfusion and stabilize blood pressure.

A patient with significant mitral regurgitation secondary to papillary muscle dysfunction following a myocardial infarction is experiencing worsening hyperkalemia despite CRRT. The nephrology team has adjusted the CRRT parameters, and the medical team has administered calcium gluconate and insulin with glucose. Given the patient's current condition, which of the following nursing interventions is most critical to prevent immediate life-threatening complications?

A) Monitor the patient's cardiac rhythm continuously and prepare for potential emergency interventions.

B) Increase the frequency of blood pressure monitoring to detect hypotensive episodes.

C) Schedule regular neurological assessments to monitor for changes in mental status.

D) Coordinate with dietary services to restrict potassium intake immediately.

MI - Nursing Case Study

Pathophysiology

• Primary mechanism: Atherosclerotic plaque rupture leads to thrombogenesis, occluding the coronary artery and reducing myocardial blood flow, causing ischemia and subsequent necrosis of cardiac tissue.

• Secondary mechanism: The imbalance between oxygen supply and demand triggers anaerobic metabolism in cardiac myocytes, resulting in lactic acid accumulation and further cellular injury.

• Key complication: Myocardial necrosis can lead to impaired contractility, increasing the risk of heart failure, arrhythmias like ventricular fibrillation, and cardiogenic shock due to compromised cardiac output.

Patient Profile

Demographics:

62-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Hyperlipidemia, Chronic Kidney Disease Stage 3

• Current medications: Metoprolol, Lisinopril, Metformin, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe chest pain radiating to the left arm and jaw

• Key symptoms: Shortness of breath, diaphoresis, nausea, dizziness

• Vital signs: Blood pressure 88/56 mmHg, heart rate 122 bpm, respiratory rate 28 breaths per minute, temperature 37.2°C (99°F), oxygen saturation 88% on room air

Section 1

Following the initial presentation, the patient was rapidly assessed in the emergency department. A 12-lead ECG revealed significant ST-segment elevation in the inferior leads, consistent with an acute inferior myocardial infarction. In addition to these findings, the patient's jugular venous pressure was noted to be elevated, suggesting right-sided heart involvement. Breath sounds were diminished at the bases, and crackles were audible, indicating potential pulmonary edema. The patient's skin was cold and clammy, with peripheral cyanosis, highlighting compromised perfusion. Laboratory results showed elevated cardiac biomarkers including troponin I and CK-MB, suggestive of ongoing myocardial injury. Blood glucose was notably elevated at 256 mg/dL, complicating metabolic demands.

As the patient's condition evolved, a sudden change in status was observed. The patient experienced an episode of ventricular fibrillation, a life-threatening arrhythmia requiring immediate resuscitation. Advanced cardiac life support protocols were initiated, including defibrillation and administration of intravenous amiodarone, which successfully restored sinus rhythm. Despite this, the patient remained hemodynamically unstable, with a blood pressure of 78/50 mmHg and continued oxygen desaturation to 85% despite supplemental oxygen. Further investigations revealed a new, significant rise in serum creatinine to 2.8 mg/dL, indicating worsening renal function possibly due to decreased renal perfusion and nephrotoxic medications.

In light of these findings, the medical team faced a complex challenge of managing the patient's multifaceted condition. The necessity of balancing reperfusion strategies, such as percutaneous coronary intervention, with the risk of contrast-induced nephropathy required careful consideration. Additionally, the development of acute kidney injury exacerbated the patient's fluid overload, prompting the need for judicious diuretic use while closely monitoring renal function. The ongoing risk of recurrent arrhythmias necessitated continuous cardiac monitoring and potential consideration for anti-arrhythmic prophylaxis. This intricate clinical picture required coordinated, multidisciplinary efforts to optimize cardiac function, manage renal complications, and stabilize the patient's condition.

Section 2

As the team continued to navigate the complexities of the patient's condition, a new diagnostic result emerged that required immediate attention. A repeat 12-lead ECG and echocardiogram were performed to reassess cardiac function and evaluate for any mechanical complications. The echocardiogram revealed a new finding of moderate mitral regurgitation, likely secondary to papillary muscle dysfunction from the inferior myocardial infarction. This regurgitation was contributing to the patient's pulmonary congestion and worsening respiratory status. Concurrently, the ECG showed persistent ST-segment elevation, raising concerns for ongoing ischemia and incomplete myocardial reperfusion.

With these findings, the team refined their approach to manage the patient's hemodynamic instability. Given the significant mitral regurgitation and the ongoing risk of arrhythmias, discussions were initiated regarding the potential need for intra-aortic balloon pump (IABP) support to improve coronary perfusion and reduce left ventricular afterload. The decision was made to optimize medical management first, increasing the dose of intravenous nitroglycerin to reduce cardiac workload and improve symptomatology while carefully monitoring blood pressure and renal function.

The emergence of mitral regurgitation added another layer of complexity, particularly concerning the patient's fluid status and respiratory distress. The necessity to manage fluid overload became paramount, and a low-dose infusion of furosemide was cautiously initiated. The patient's renal function was vigilantly monitored, with serial creatinine levels and urine output assessments guiding further adjustments in diuretic therapy. The multidisciplinary team, including cardiology, nephrology, and critical care specialists, collaborated closely to address the dynamic interplay of cardiac and renal factors, ensuring that each therapeutic decision was meticulously balanced against potential risks and benefits. This coordinated effort aimed to stabilize the patient while preparing for potential invasive interventions should the conservative measures prove insufficient.

Section 3

As the team continued to monitor the patient's response to the adjusted treatment plan, a change in the patient's status became evident. The patient began exhibiting signs of acute decompensation, characterized by increased respiratory distress, decreased oxygen saturation levels dropping to 85% on high-flow nasal cannula, and a sudden drop in blood pressure to 85/50 mmHg. Auscultation of the lungs revealed bilateral crackles, indicative of worsening pulmonary edema, while jugular venous distention suggested increasing right-sided heart pressures. The patient's heart rate remained elevated at 115 beats per minute, with new-onset atrial fibrillation noted on telemetry, complicating the hemodynamic status further.

Laboratory results showed a rising B-type Natriuretic Peptide (BNP) level, now elevated at 1200 pg/mL, consistent with worsening heart failure. Despite the cautious administration of furosemide, the patient's urine output remained marginal, with a urine output of less than 20 mL/hour, raising concerns for acute kidney injury. The most recent serum creatinine level had increased to 2.1 mg/dL from a baseline of 1.2 mg/dL, prompting the nephrology team to reassess the renal function and fluid management strategy urgently. Arterial blood gas analysis revealed a mixed respiratory and metabolic acidosis, with a pH of 7.28, pCO2 of 55 mmHg, and HCO3- of 18 mEq/L, necessitating immediate intervention to prevent further respiratory compromise.

The emergence of these complications required the team to reconsider the current treatment strategy. The decision was made to initiate non-invasive positive pressure ventilation to improve oxygenation and reduce the work of breathing, while simultaneously preparing for the urgent placement of an intra-aortic balloon pump to enhance cardiac output and perfusion pressure. The multidisciplinary team, aware of the delicate balance between aggressive intervention and potential adverse effects, continued to discuss the timing of potential surgical intervention for mitral valve repair or replacement. This ongoing evaluation underscored the critical need for dynamic clinical reasoning, as the patient's condition remained precarious, and the risk of further deterioration loomed.

Section 4

The implementation of non-invasive positive pressure ventilation led to a slight improvement in the patient's oxygen saturation, now stabilizing at 89%. However, the team remained vigilant, recognizing the possibility of further deterioration. Despite these efforts, the patient's blood pressure continued to fluctuate, with readings as low as 80/45 mmHg, indicating persistent hemodynamic instability. The intra-aortic balloon pump was successfully placed, and initial monitoring showed a modest improvement in cardiac output, as evidenced by an increase in systolic blood pressure to 90 mmHg. Yet, the patient's clinical picture remained precarious, requiring careful titration of vasopressors to maintain adequate perfusion.

The nephrology team reviewed the patient's renal status, noting the continued rise in serum creatinine to 2.6 mg/dL, suggesting ongoing acute kidney injury. In light of the patient's declining renal function, the decision was made to initiate continuous renal replacement therapy (CRRT) to manage fluid overload and electrolyte imbalances, aiming to prevent further cardiac and renal compromise. Meanwhile, the cardiology team re-evaluated the potential need for surgical intervention, weighing the risks and benefits of proceeding with mitral valve repair in the context of the patient's unstable condition.

Despite these interventions, a new complication emerged: the patient developed signs of systemic infection, with a sudden spike in body temperature to 39°C and laboratory results indicating leukocytosis with a white blood cell count of 16,000/mm³. Blood cultures were promptly obtained, and broad-spectrum antibiotics were initiated empirically. The infectious disease specialist was consulted to guide antimicrobial therapy, considering the possibility of endocarditis or another source of sepsis complicating the patient's course. This new development further challenged the multidisciplinary team, necessitating a reassessment of the treatment priorities and a coordinated approach to address the evolving complexity of the patient's condition.

Section 5

As the critical care team continued to monitor the patient, new diagnostic results revealed concerning developments. A transesophageal echocardiogram (TEE) was performed to assess the cardiac structures in detail. The TEE uncovered significant mitral regurgitation, likely exacerbated by papillary muscle dysfunction secondary to the myocardial infarction. This finding correlated with the patient's persistent hemodynamic instability and fluctuating blood pressure. Additionally, the echocardiogram showed a small vegetation on the mitral valve, raising suspicion for infective endocarditis as the potential source of the systemic infection. These results prompted a re-evaluation of the patient's treatment plan, with discussions centering around the feasibility and timing of surgical intervention versus continued medical management.

Meanwhile, the patient's renal function showed no signs of improvement despite the initiation of CRRT. Laboratory results indicated worsening hyperkalemia, with serum potassium levels climbing to 6.2 mmol/L. This electrolyte imbalance posed an immediate cardiac risk, necessitating urgent intervention to prevent life-threatening arrhythmias. The nephrology team adjusted the CRRT parameters to enhance potassium clearance while the medical team administered calcium gluconate and insulin with glucose to stabilize cardiac cell membranes and promote intracellular potassium shift.

The patient's clinical status remained tenuous, with episodes of ventricular tachycardia briefly complicating the course of care. These arrhythmias were managed with antiarrhythmic medications and adjustments to the vasopressor regimen to optimize myocardial perfusion. The multidisciplinary team faced a formidable challenge as they navigated the intertwined complications of cardiac, renal, and infectious nature. Decisive action was required to balance the risks of surgical intervention against the immediate need to address the mitral valve dysfunction and potential endocarditis, all while maintaining hemodynamic stability and preventing further deterioration.